447 filings
10-Q
2024 Q2
ANIX
Anixa Biosciences Inc
Quarterly report
4 Jun 24
5:00pm
8-K
ANIX
Anixa Biosciences Inc
8 May 24
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
8:35am
8-K
ANIX
Anixa Biosciences Inc
22 Mar 24
Submission of Matters to a Vote of Security Holders
4:30pm
10-Q
2024 Q1
ANIX
Anixa Biosciences Inc
Quarterly report
12 Mar 24
5:00pm
DEF 14A
ANIX
Anixa Biosciences Inc
Definitive proxy
8 Feb 24
4:15pm
S-8
4i60qte jkby4
16 Jan 24
Registration of securities for employees
4:43pm
8-K
lgh5awo2r0mirtnqll
7 Dec 23
Regulation FD Disclosure
6:01am
8-K
f6c3x1kt
17 Apr 23
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
1:45pm
8-K
ysgu5i
10 Mar 23
Submission of Matters to a Vote of Security Holders
8:00am
S-8
uu6rxnmdv5
4 Jan 23
Registration of securities for employees
5:05pm
8-K
t5m7wuyvs 7z68s
8 Dec 22
Regulation FD Disclosure
8:40am
8-K
4ut4m1bcqz4zxkduvfmf
29 Sep 22
Regulation FD Disclosure
8:30am
EFFECT
0lghn
20 Sep 22
Notice of effectiveness
12:15am
CORRESP
qnavfmx us1wme1savg
15 Sep 22
Correspondence with SEC
12:00am